AbbVie: Allergan Aesthetics Reports Improved Satisfaction With Facial Appearance Following Aesthetic Treatment in Two Studies of Patients on GLP-1 ... - FinanzNachrichten.de

HARMONY IN DIVERSITY is the first study of combined neurotoxin and filler treatment in adults on glucagon-like peptide-1 (GLP-1) medications. In this Phase 4 cohort, participants reported statisticall ...
AbbVie News Center

Allergan Aesthetics Reports Improved Satisfaction With Facial Appearance Following Aesthetic Treatment in Two Studies of Patients on GLP-1 Medications

HARMONY IN DIVERSITY is the first study of combined neurotoxin and filler treatment in adults on glucagon-like peptide-1 (GLP-1) medications. In this Phase 4 cohort, participants ...
Singapore Business Review

Hugel targets wider Singapore demand beyond aesthetics

Hugel Inc. is looking to widen demand for its botulinum toxin products in Singapore beyond aesthetic medicine as it develops additional therapeutic indications.